PRO News and Press, PROS Holdings Inc. From 10/31/23

2023-10-31 16:22:29 ET More on PROS Holdings PROS Holdings may be worth low $40s a share in a takeover - analyst PROS Holdings jumps amid report of takeover interest Seeking Alpha’s Quant Rating on PROS Holdings Historical earnings data for PROS Holdin...

PROS raises its revenue and profitability outlook for the full year 2023 after exceeding the Company’s Q3 guidance ranges across all metrics. Subscription revenue of $60.0 million, up 16% year-over-year. Total revenue of $77.3 million, up 10% year-over-year. Subscription gross ...

Tennant Company (TNC) is expected to report for Q3 2023 Stellantis N.V. (STLA) is expected to report for Q3 2023 Marathon Petroleum Corporation (MPC) is expected to report $7.79 for Q3 2023 Easterly Government Properties Inc. (DEA) is expected to report $0.29 for Q3 2023 Allegion ...

PROS Holdings Inc. (PRO) is expected to report $-0.15 for Q3 2023

2023-10-16 10:25:35 ET More on ProKidney REACT Or Retreat: ProKidney's Phase 3 Focal Point For further details see: Prokidney says Palihapitiya Chamath sells ~486.9K shares

PROS ® (NYSE: PRO), a leading provider of AI-powered SaaS pricing, CPQ, revenue management, and digital offer marketing solutions, will release its financial results for the third quarter 2023 ended September 30, 2023 after the U.S. financial markets close on Tuesday, October 31, 2023. ...

2023-09-28 15:45:21 ET More on PROS Holdings PROS Holdings, Inc. (PRO) Q2 2023 Earnings Call Transcript PROS Holdings Sees Strong Travel Activity But Slower Growth In 2023 PROS Holdings jumps amid report of takeover interest Seeking Alpha’s Quant Ratin...

2023-09-27 14:58:39 ET More on Technology Select Sector Energy (XLE) Vs. Tech (XLK) Is Like Djokovic Vs. Federer Tech Stocks Aren't Done: Strong Buy On XLK Energy In, Tech Out Technology Select Sector SPDR ETF declares quarterly distribution of $0.3603 ...

2023-09-27 10:01:07 ET More on PROS Holdings PROS Holdings, Inc. (PRO) Q2 2023 Earnings Call Transcript PROS Holdings Sees Strong Travel Activity But Slower Growth In 2023 Seeking Alpha’s Quant Rating on PROS Holdings Historical earnings data for PROS ...

2023-09-05 08:42:44 ET Insmed Incorporated ( NASDAQ: INSM ) added ~7% pre-market Tuesday after announcing that a Phase 3 trial for its antibiotic Arikayce reached the main goal in adults with a type of bacterial lung infection. The Phase 3b placebo-controlled trial involved ...